Literature DB >> 9070586

Poststroke late seizures and their role in rehabilitation of inpatients.

S Paolucci1, G Silvestri, S Lubich, L Pratesi, M Traballesi, G L Gigli.   

Abstract

PURPOSE: This study was designed to (a) identify the prevalence of poststroke late seizures in a population of patients admitted to rehabilitation of neurologic sequelae of their first stroke, (b) recognize reliable prognostic factors associated with the occurrence of poststroke late seizures, and (c) evaluate the impact of seizures on the results of rehabilitation treatment.
METHODS: In a prospective study of 306 consecutive patients admitted to a rehabilitation hospital for sequelae of their first stroke, we assessed the relation among 15 independent variables and the development of seizures by using multiple regression analysis (forward stepwise). In addition, we evaluated the impact of occurrence of poststroke seizures on both efficiency and effectiveness of rehabilitation and length of stay.
RESULTS: Poststroke late seizures occurred in 46 (15.03%) patients, with a mean interval from stroke of 101.98 +/- 37.96 days. In multiple regression analysis, putaminal and lobar hemorrhages showed a significant positive association with the development of seizures (p < 0.005), whereas high scores on the Canadian Neurological Scale (CNS) (indicating less severe strokes) and increasing age were negatively associated (p < 0.01 and p < 0.05, respectively). Patients with putaminal and lobar hemorrhages and patients with severe stroke (CNS score at admission, <7) were at significantly greater relative risk of seizures [relative risk (RR) = 1.99, 95% confidence interval (CI), 1.11-1.39; RR = 3.00, CI, 1.06-1.13; and RR = 2.41, CI, 1.01-1.27, respectively). No significant association was found between poststroke seizures and results of rehabilitation.
CONCLUSIONS: Poststroke late seizures occurred mainly in patients with putaminal and lobar hemorrhagic strokes but, if treated, did not affect rehabilitation therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9070586     DOI: 10.1111/j.1528-1157.1997.tb01115.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Post-stroke seizures.

Authors:  G L Gigli; S Paolucci; G Silvestri
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  Epileptogenesis after experimental focal cerebral ischemia.

Authors:  Heli Karhunen; Jukka Jolkkonen; Juhani Sivenius; Asla Pitkänen
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 3.  Poststroke epilepsy: update and future directions.

Authors:  Johan Zelano
Journal:  Ther Adv Neurol Disord       Date:  2016-06-24       Impact factor: 6.570

4.  Can neural network able to estimate the prognosis of epilepsy patients according to risk factors?

Authors:  Kezban Aslan; Hacer Bozdemir; Cenk Sahin; S Noyan Ogulata
Journal:  J Med Syst       Date:  2009-03-28       Impact factor: 4.460

Review 5.  Management of seizures in critically ill patients.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

Review 6.  Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.

Authors:  Richard S Chang; William Cy Leung; Michael Vassallo; Lucy Sykes; Emma Battersby Wood; Joseph Kwan
Journal:  Cochrane Database Syst Rev       Date:  2022-02-07

Review 7.  [Seizures and epilepsies after stroke].

Authors:  H M Hamer
Journal:  Nervenarzt       Date:  2009-04       Impact factor: 1.214

8.  Early predictors and prevention for post-stroke epilepsy: changes in neurotransmitter levels.

Authors:  Wen-Jing Xie; Ming Dong; Qun Liu; Hong-Mei Meng
Journal:  Transl Neurosci       Date:  2016-02-18       Impact factor: 1.757

9.  Post-stroke epilepsy in young adults: a long-term follow-up study.

Authors:  Renate Arntz; Loes Rutten-Jacobs; Noortje Maaijwee; Hennie Schoonderwaldt; Lucille Dorresteijn; Ewoud van Dijk; Frank-Erik de Leeuw
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.